Nemus Bioscience Glaucoma Drug to Be Made by Albany Molecular Research
Long Beach, CA-based Nemus Bioscience, Inc. (OTC: NMUS) signed an agreement on Aug. 01, 2018 with Albany Molecular Research (AMRI) for the manufacture of Nemus’ proprietary cannabinoid-based active pharmaceutical ingredients (API) for glaucoma.
AMRI has expertise in the synthesis of Nemus’ proprietary prodrug of THC. This molecule forms the basis of NB1111, Nemus’ compound in development for the treatment of glaucoma.
“Advancing into the manufacturing stage…is pivotal for initiating human studies,” said Dr. Brian Murphy, CEO of Nemus. “Cannabinoid-based therapies have the potential to revolutionize glaucoma therapy by lowering intraocular pressure, and…(protecting) the cells of the optic nerve, thereby preserving vision.”
Source Nemus press release
Nemus Bioscience Glaucoma Drug to Be Made by Albany Molecular Research
About Cannin.com: Your Marijuana Stocks Resource
Cannin is your #1 resource for marijuana stocks. Our global team of experts evaluates all emerging marijuana stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana stock investments for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Many market analysts expect the legal marijuana industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana stocks is now.
Are you interested in marijuana stocks like Curaleaf, Trulieve, Aurora Cannabis, or Charlotte’s Web,?
Are you looking to buy stock in marijuana companies for 2020? Interested in emerging penny marijuana stocks? Looking for the best Canadian marijuana stocks to invest in? We can help.
Predict price movements of marijuana stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- 108% Backtested since 2012
We’re so confident you’ll love our algotrading marijuana stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best marijuana stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks 2020
